Medicare Part D, the outpatient prescription drug benefit for Medicare beneficiaries, provides coverage above a catastrophic threshold for high out-of-pocket drug costs, but there is no cap on total out-of-pocket drug costs that beneficiaries pay each year. Recent legislative proposals would add a cap on out-of-pocket spending under Part D. This analysis focuses on the potential impact of different out-of-pocket spending caps in terms of how many beneficiaries would be affected and how much they could save.
Budget Basics: What Is Medicare Advantage?
Biden Unveils Plan for Medicare Funding in $6.8 Trillion Budget
Big Changes in Medicare ABCD for 2024
Part D Out-of-Pocket Smoothing Policy Raises Implementation
Proposed 'Flat Copayment Policy' Will Save Medicare Part D
Medicare price negotiation: A paradigm shift in Part D access and cost
Key Facts About Medicare Part D Enrollment and Costs in 2023
PDF) Factors Associated With Prescriptions for Branded Medications
How is Medicare Part D Changing in 2024?
How Will the Prescription Drug Provisions in the Inflation
CMS releases 2024 Medicare Part D benefit parameters - Buck
How Would Sharing Rebates at the Point-Of-Sale Affect Beneficiary
Your Medicare Part D Costs Might Fall in 2025. Here's Why
Explaining the Prescription Drug Provisions in the Build Back Better Act
As Congress Weighs Legislation, New Report Examines How Caps on Part D Spending Would Affect People with Medicare - Medicare Rights Center